Literature DB >> 19805729

Relative preservation of MMSE scores in autopsy-proven dementia with Lewy bodies.

P T Nelson1, R J Kryscio, G A Jicha, E L Abner, F A Schmitt, L O Xu, G Cooper, C D Smith, W R Markesbery.   

Abstract

BACKGROUND: Recent studies raised questions about the severity of cognitive impairment associated with dementia with Lewy bodies (DLB). However, there have been few analyses of large, multicenter data registries for clinical-pathologic correlation.
METHODS: We evaluated data from the National Alzheimer's Coordinating Center registry (n = 5,813 cases meeting initial inclusion criteria) and the University of Kentucky Alzheimer's Disease Center autopsy series (n = 527) to compare quantitatively the severity of cognitive impairment associated with DLB pathology vs Alzheimer disease (AD) and AD+DLB pathologies.
RESULTS: Mini-Mental State Examination (MMSE) scores showed that persons with pure DLB had cognitive impairment of relatively moderate severity (final MMSE score 15.6 +/- 8.7) compared to patients with pure AD and AD+DLB (final MMSE score 10.7 +/- 8.6 and 10.6 +/- 8.6). Persons with pure DLB pathology from both data sets had more years of formal education and were more likely to be male. Differences in final MMSE scores were significant (p < 0.01) between pure DLB and both AD+DLB and pure AD even after correction for education level, gender, and MMSE-death interval. Even in cases with extensive neocortical LBs, the degree of cognitive impairment was most strongly related to the amount of concomitant AD-type neurofibrillary pathology.
CONCLUSIONS: Dementia with Lewy bodies can constitute a debilitating disease with associated psychiatric, motoric, and autonomic dysfunction. However, neocortical Lewy bodies are not a substrate for severe global cognitive impairment as assessed by the Mini-Mental State Examination. Instead, neocortical Lewy bodies appear to constitute or reflect an additive disease process, requiring Alzheimer disease or other concomitant brain diseases to induce severe global cognitive deterioration.

Entities:  

Mesh:

Year:  2009        PMID: 19805729      PMCID: PMC2764396          DOI: 10.1212/WNL.0b013e3181bacf9e

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  40 in total

1.  Lewy body pathology is a frequent co-pathology in familial Alzheimer's disease.

Authors:  Yuri Trembath; Carolyn Rosenberg; John F Ervin; Donald E Schmechel; Perry Gaskell; Margaret Pericak-Vance; Jeffery Vance; Christine M Hulette
Journal:  Acta Neuropathol       Date:  2003-02-11       Impact factor: 17.088

2.  Severity of cognitive impairment and the clinical diagnosis of AD with Lewy bodies.

Authors:  O L Lopez; R L Hamilton; J T Becker; S Wisniewski; D I Kaufer; S T DeKosky
Journal:  Neurology       Date:  2000-05-09       Impact factor: 9.910

3.  Antemortem diagnosis of diffuse Lewy body disease.

Authors:  H A Crystal; D W Dickson; J E Lizardi; P Davies; L I Wolfson
Journal:  Neurology       Date:  1990-10       Impact factor: 9.910

4.  Alpha-synuclein pathology is highly dependent on the case selection.

Authors:  L Parkkinen; H Soininen; M Laakso; I Alafuzoff
Journal:  Neuropathol Appl Neurobiol       Date:  2001-08       Impact factor: 8.090

5.  Lewy body-related alpha-synucleinopathy in the aged human brain.

Authors:  K A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2004-04-02       Impact factor: 3.575

6.  A comparison of episodic memory deficits in neuropathologically-confirmed Dementia with Lewy bodies and Alzheimer's disease.

Authors:  Joanne M Hamilton; David P Salmon; Douglas Galasko; Dean C Delis; Lawrence A Hansen; Eliezer Masliah; Ronald G Thomas; Leon J Thal
Journal:  J Int Neuropsychol Soc       Date:  2004-09       Impact factor: 2.892

7.  Regional distribution of alpha-synuclein pathology in unimpaired aging and Alzheimer disease.

Authors:  Laura Parkkinen; Hilkka Soininen; Irina Alafuzoff
Journal:  J Neuropathol Exp Neurol       Date:  2003-04       Impact factor: 3.685

8.  Influence of Alzheimer pathology on clinical diagnostic accuracy in dementia with Lewy bodies.

Authors:  A R Merdes; L A Hansen; D V Jeste; D Galasko; C R Hofstetter; G J Ho; L J Thal; J Corey-Bloom
Journal:  Neurology       Date:  2003-05-27       Impact factor: 9.910

Review 9.  Dementia with Lewy bodies.

Authors:  Ian McKeith; Jacobo Mintzer; Dag Aarsland; David Burn; Helen Chiu; Jiska Cohen-Mansfield; Dennis Dickson; Bruno Dubois; John E Duda; Howard Feldman; Serge Gauthier; Glenda Halliday; Brian Lawlor; Carol Lippa; Oscar L Lopez; João Carlos Machado; John O'Brien; Jeremy Playfer; Wayne Reid
Journal:  Lancet Neurol       Date:  2004-01       Impact factor: 44.182

10.  Prodromal clinical manifestations of neuropathologically confirmed Lewy body disease.

Authors:  G A Jicha; F A Schmitt; E Abner; P T Nelson; G E Cooper; C D Smith; W R Markesbery
Journal:  Neurobiol Aging       Date:  2008-11-20       Impact factor: 4.673

View more
  34 in total

1.  Reliability of repeated cognitive assessment of dementia using a brief computerized battery.

Authors:  Dustin Hammers; Elizabeth Spurgeon; Kelly Ryan; Carol Persad; Judith Heidebrink; Nancy Barbas; Roger Albin; Kirk Frey; David Darby; Bruno Giordani
Journal:  Am J Alzheimers Dis Other Demen       Date:  2011-06-01       Impact factor: 2.035

2.  National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach.

Authors:  Thomas J Montine; Creighton H Phelps; Thomas G Beach; Eileen H Bigio; Nigel J Cairns; Dennis W Dickson; Charles Duyckaerts; Matthew P Frosch; Eliezer Masliah; Suzanne S Mirra; Peter T Nelson; Julie A Schneider; Dietmar Rudolf Thal; John Q Trojanowski; Harry V Vinters; Bradley T Hyman
Journal:  Acta Neuropathol       Date:  2011-11-20       Impact factor: 17.088

3.  National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease.

Authors:  Bradley T Hyman; Creighton H Phelps; Thomas G Beach; Eileen H Bigio; Nigel J Cairns; Maria C Carrillo; Dennis W Dickson; Charles Duyckaerts; Matthew P Frosch; Eliezer Masliah; Suzanne S Mirra; Peter T Nelson; Julie A Schneider; Dietmar Rudolf Thal; Bill Thies; John Q Trojanowski; Harry V Vinters; Thomas J Montine
Journal:  Alzheimers Dement       Date:  2012-01       Impact factor: 21.566

Review 4.  Pathologic correlates of dementia in individuals with Lewy body disease.

Authors:  Joshua A Sonnen; Nadia Postupna; Eric B Larson; Paul K Crane; Shannon E Rose; Kathleen S Montine; James B Leverenz; Thomas J Montine
Journal:  Brain Pathol       Date:  2010-05       Impact factor: 6.508

5.  Neurodegeneration-associated instability of ribosomal DNA.

Authors:  Justin Hallgren; Maciej Pietrzak; Grzegorz Rempala; Peter T Nelson; Michal Hetman
Journal:  Biochim Biophys Acta       Date:  2014-01-02

6.  Using the Folstein Mini Mental State Exam (MMSE) to explore methodological issues in cognitive aging research.

Authors:  Todd Monroe; Michael Carter
Journal:  Eur J Ageing       Date:  2012-06-15

7.  Effect of common neuropathologies on progression of late life cognitive impairment.

Authors:  Lei Yu; Patricia A Boyle; Sue Leurgans; Julie A Schneider; Richard J Kryscio; Robert S Wilson; David A Bennett
Journal:  Neurobiol Aging       Date:  2015-04-22       Impact factor: 4.673

8.  University of Kentucky Sanders-Brown healthy brain aging volunteers: donor characteristics, procedures and neuropathology.

Authors:  Frederick A Schmitt; Peter T Nelson; Erin Abner; Stephen Scheff; Gregory A Jicha; Charles Smith; Gregory Cooper; Marta Mendiondo; Deborah D Danner; Linda J Van Eldik; Allison Caban-Holt; Mark A Lovell; Richard J Kryscio
Journal:  Curr Alzheimer Res       Date:  2012-07       Impact factor: 3.498

9.  Cognitive impairment, decline and fluctuations in older community-dwelling subjects with Lewy bodies.

Authors:  J A Schneider; Z Arvanitakis; L Yu; P A Boyle; S E Leurgans; D A Bennett
Journal:  Brain       Date:  2012-10       Impact factor: 13.501

10.  Amyloid-β deposition and regional grey matter atrophy rates in dementia with Lewy bodies.

Authors:  Lidia Sarro; Matthew L Senjem; Emily S Lundt; Scott A Przybelski; Timothy G Lesnick; Jonathan Graff-Radford; Bradley F Boeve; Val J Lowe; Tanis J Ferman; David S Knopman; Giancarlo Comi; Massimo Filippi; Ronald C Petersen; Clifford R Jack; Kejal Kantarci
Journal:  Brain       Date:  2016-07-24       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.